Leveraging rapid technological advances for human health is a global trend, driving the rise of biomedical engineering ...

H ave you noticed people everywhere wearing continuous glucose monitors (CGM)? On the subway, at the gym, in the grocery ...

After collecting FDA green lights for 90- and 180-day versions, the agency has cleared the latest generation of the Eversense ...

Continuous glucose monitoring, compared with fingerstick tests, was feasible and accurate in an inpatient setting among patients and nurses.

If a patient receives a continuous glucose monitor device through their medical benefit, they may be more adherent and may ...

Senseonics (NYSE:SENS) announced today that it received FDA clearance for its next-generation Eversense 365 CGM system.

Remote patient monitoring has exploded since the pandemic. In just four years from the beginning of 2019 through 2022, ...

Eversense 365 cleared in the U.S. as an integrated continuous glucose monitoring (iCGM) system for people with diabetesWith a single sensor, the ...

Continuous Glucose Monitoring (CGM) Systems Market The increasing incidence of diabetes and the detection of patient's blood glucose levels are raising the demand for continuous global monitoring ...

A new study from researchers at the BU Chobanian & Avedisian School of Mediicne have that found that non-diabetic individuals using continuous glucose monitoring sensors  spend a much larger period of ...

Real-world data showed reductions in healthcare resource utilization and improved glycemic control over 1 year with ...

As part of its ongoing exploration of vocal biomarkers and the role they can play in enhancing health outcomes, Klick Labs ...